U.S. Near Infrared Imaging Market Size And Forecast
U.S. Near Infrared Imaging Market size was valued at USD 64.87 Million in 2024 and is projected to reach USD 85.95 Million by 2032, growing at a CAGR of 3.58% from 2026 to 2032.
The increasing prevalence of chronic diseases is playing a major role in the growth of the U.S. Near Infrared Imaging Market. The U.S. Near Infrared Imaging Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
U.S. Near Infrared Imaging Market Definition
Near-Infrared (NIR) Imaging uses near infrared light between 650 and 950 nm in order to be able to non-invasively examine the concentration and oxygenation of haemoglobin in the brain, muscle and other tissues. The diagnostic tool is used to detect changes that are induced by disease, injury, or brain activity. When considering brain studies, NIR can be said to complement functional magnetic resonance imaging (fMRI) as it provides measures of both oxygenated and deoxygenated haemoglobin concentrations. NIR is said to 'enable studies in populations of subjects with experimental paradigms that are not amenable to fMRI'.
U.S. Near Infrared Imaging Market Overview
The increasing prevalence of chronic diseases is playing a major role in the growth of the near-infrared imaging market. The United States is a major contributor to the near-infrared imaging market partly due to the prevalence of cancer treatment and its research as well as the rising older population in the United States. The rising older population is playing a key role in the increased requirement for diagnosis through tools such as near-infrared imaging.
Near-infrared imaging is being increasingly adopted for studies in cancer treatment, diseases involving the joint, major neurological diseases, and more. Despite the progression of technology and the increasing popularity of advanced optical methodologies such as NIR, there are still limitations that are associated with its implementation such as the lack of awareness or skill required for the operation of the system.
U.S. Near Infrared Imaging Market Segmentation Analysis
The U.S. Near Infrared Imaging Market is segmented on the basis of Product, Application, and End-User.
U.S. Near Infrared Imaging Market, By Product
- Near Infrared Fluorescence Imaging Systems
- Near Infrared Fluorescence & Bioluminescence Imaging Systems
- On the basis of Product, the U.S. Near Infrared Imaging Market has been segmented into Near Infrared Fluorescence Imaging Systems and Near Infrared Fluorescence and bioluminescence Imaging Systems. Near Infrared Fluorescence Imaging Systems accounted for the largest market share during the forecast period. Near-infrared fluorescence (NIRF) molecular imaging comprises of great potential as a new "point-of-care" medical imaging modality. It can provide the sensitivity of nuclear medicine techniques. In recent times, designs of a variety of NIRF imaging devices have emerged in the market. They have also been used in investigational clinical studies using indocyanine green (ICG) as a non-targeting NIRF contrast agent in order to demark the blood and lymphatic vasculatures both non-invasively and intraoperatively.
U.S. Near Infrared Imaging Market, By Application
- Preclinical Imaging
- Medical Imaging
- Clinical Imaging
- On the basis of Application, the market is classified into Preclinical Imaging, Medical Imaging, and Clinical Imaging. U.S. Near Infrared Imaging Market for Medical Imaging applications is expected to be fastest growing during the forecast period. Near infrared imaging process utilizes ear infrared light between 650 and 950 nm in order to non-invasively probe the concentration and oxygenation of hemoglobin in the brain, muscle and other tissues. It is used for detecting various medical conditions such as detecting changes induced by brain activity, injury, or disease.
U.S. Near Infrared Imaging Market, By End-User
- Hospitals and Clinics
- Research Laboratories
- Others
- On the basis of End Users, the U.S. Near Infrared Imaging Market has been segmented into Hospitals and Clinics, Research Laboratories, and Others. Among these, Hospitals and Clinics accounted for the largest market share during the forecast period. Near infrared imagine is used in-hospital and clinic settings for non-invasive monitoring and the diagnosis of patients who may require surgical intervention. It helps in providing information regarding oxygen saturation of hemoglobin within the microcirculation
Key Players
- The "U.S. Near Infrared Imaging Market" is highly fragmented with the presence of a large number of major companies including Hamamatsu Photonics K.K., Karl Storz Se & Co. Kg, Li-Cor, Inc., Medtronic PLC., Perkinelmer Inc., Shimadzu Corporation, Stryker, and Zeiss.
- Medtronic PLC., Perkinelmer Inc., Stryker, Shimadzu Corporation, and Hamamatsu Photonics K.K are some of the top five players in the U.S. Near Infrared Imaging Market. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players.
Key Developments
- In 2018, Medtronic acquired VisionSense, an Israel-based firm that develops imaging and visualization technologies for minimally invasive procedures. The corporation was able to obtain access to VisionSense's near-infrared imaging equipment as a result of this.
- Bracco Imaging joined the near-infrared imaging industry in 2017 with the purchase of SurgVision. Surgvision is a start-up focusing on the development of fluorescent image-guided surgical platform solutions employing high-definition cameras and tracers. Bracco's offering of imaging solutions for cancer healthcare professionals has been enhanced with the purchase of Surgvision.
- Stryker acquired USD 701 million for NOVADAQ Technologies Inc., a leading developer of fluorescence imaging technologies that allow surgeons to visualize blood flow in vessels and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures. Stryker became a prominent player in the near-infrared market as a result of this strategic purchase.